Hypoglycemia clinical trials at UCSF

1 research study open to eligible people

Hypoglycemia is when your blood sugar level goes unusually low. UCSF is conducting research to test a new treatment for Type 1 diabetes called VX-880, focusing on its safety and effectiveness. The research checks if the treatment can be safely administered to participants.

Showing trials for

  • VX-880 in Participants With Type 1 Diabetes

    open to eligible people ages 18-65

    This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

    San Francisco, California and other locations

Last updated: